NCT06170528Completed
ARUA-ALZ - Connecting Audio and Radio SensingmSystems to Improve Care at Home for ADRD
ARUA-ALZ - Connecting Audio and Radio Sensing Systems to Improve Care at Home for ADRD
Source: ClinicalTrials.gov · Last updated 23 Aug 2024
Brief summary (registry, in English)
The purpose of this study is to address the unmet care needs and reduce the care burdens for persons with ADRD (Alzheimer's Disease and Alzheimer's Disease Related Dementias) and their caregivers by providing monitoring of daily activities and gestures using audio and radio sensing, providing voice-based reminders intervention. In phase 1, dyads will participate in two focus groups will take 60 minutes per each. In Phase 2, AURA\_ALZ (connecting Audio and Radio Sensing Systems-Alzheimer's Disease) will deployed for two weeks at participants' home. At the end of the two weeks, usability, acceptability of the use of the system will be measured.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 9 (actual)
- First submitted
- 19 Oct 2023
- Start date
- 16 Nov 2022
- Primary completion date
- 31 Jul 2024
- Lead sponsor
- Florida State University
- Diseases
- Alzheimer disease
- NCT number
- NCT06170528
What you commit to
- Study type: Interventional
- Participants enrolled: 9
- From 16 Nov 2022 to the primary completion date, 31 Jul 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Both individuals with less 18 years of age
Other
- Person is diagnosed with Moderate and Sever ADRD
- No caregivers living in the same household
- Both individuals within the dyads have language barriers
Who the study is looking for
- To be included, dyads of persons with ADRD and their family caregivers must meet the following criteria:
- 1 person must be diagnosed with ADRD from a physician. Caregivers must self-report that their person's dementia diagnosis from a physician and self-report Global Deterioration Scale (GDS) rating for care recipients to determine stage of dementia. Eligible participants must characterize their person's ADRD symptoms as fitting with Stages 3 and 4 (defined as mild cognitive impairment to mild dementia of Alzheimer's type),
- at least 1 caregiver living in the same household for at least 4 hours per day for at least the past 6 months,
- both individuals within the dyads be at least 18 years of age,
- both individuals within the dyads have sufficient vision and speaking capabilities to use a voice-enabled system, and
- both individuals within the dyads live in a community setting in Tallahassee or assisted living setting inTallahassee.
Age in the registry: 18 years to 110 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Florida State University College of nursing Coordinator of this site? Confirm its status | Tallahassee | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.